Giani2019 - Computational modeling to predict MAP3K8 effects as mediator of resistance to vemurafenib in thyroid cancer stem cells Lab
About lab
Computational modeling to predict MAP3K8 effects as mediator of resistance to vemurafenib in thyroid cancer stem cells. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.
Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packagegiani2019-computational-modeling-to-predict-map3k8-effects-as-me
Created2026-05-16
Updated2026-05-16
biomodels_ebicurateddrug-responsefaithfuloncologypharmacologyphysiologysbmlsystemsbiologytumor-growthvisualisation
Manifest
{
"io": {
"inputs": [
{
"name": "initial_free_egfr",
"label": "Free EGFR",
"units": "native SBML value",
"default": 10,
"maps_to": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.initial_free_egfr",
"description": "Initial Free EGFR. Sets the initial value of bundled SBML symbol `species_1`."
},
{
"name": "initial_sos_inactive",
"label": "Sos Inactive",
"units": "native SBML value",
"default": 10,
"maps_to": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.initial_sos_inactive",
"description": "Initial Sos Inactive. Sets the initial value of bundled SBML symbol `species_3`."
},
{
"name": "initial_ras_inactive",
"label": "Ras Inactive",
"units": "native SBML value",
"default": 10,
"maps_to": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.initial_ras_inactive",
"description": "Initial Ras Inactive. Sets the initial value of bundled SBML symbol `species_5`."
},
{
"name": "initial_raf1_inactive",
"label": "Raf1 Inactive",
"units": "native SBML value",
"default": 10,
"maps_to": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.initial_raf1_inactive",
"description": "Initial Raf1 Inactive. Sets the initial value of bundled SBML symbol `species_7`."
},
{
"name": "initial_mek_inactive",
"label": "Mek Inactive",
"units": "native SBML value",
"default": 10,
"maps_to": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.initial_mek_inactive",
"description": "Initial Mek Inactive. Sets the initial value of bundled SBML symbol `species_9`."
},
{
"name": "initial_erk",
"label": "ERK",
"units": "native SBML value",
"default": 10,
"maps_to": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.initial_erk",
"description": "Initial ERK. Sets the initial value of bundled SBML symbol `species_11`."
}
],
"outputs": [
{
"name": "free_egfr",
"maps_to": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.free_egfr",
"description": "Free EGFR observable. Maps to SBML symbol `species_1`."
},
{
"name": "sos_inactive",
"maps_to": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.sos_inactive",
"description": "Sos Inactive observable. Maps to SBML symbol `species_3`."
},
{
"name": "ras_inactive",
"maps_to": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.ras_inactive",
"description": "Ras Inactive observable. Maps to SBML symbol `species_5`."
},
{
"name": "raf1_inactive",
"maps_to": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.raf1_inactive",
"description": "Raf1 Inactive observable. Maps to SBML symbol `species_7`."
},
{
"name": "mek_inactive",
"maps_to": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.mek_inactive",
"description": "Mek Inactive observable. Maps to SBML symbol `species_9`."
},
{
"name": "erk",
"maps_to": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.erk",
"description": "ERK observable. Maps to SBML symbol `species_11`."
},
{
"name": "state",
"maps_to": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.state",
"description": "Full raw SBML observable record for reproducibility and downstream visualisation."
},
{
"name": "summary",
"maps_to": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.summary",
"description": "Change and peak summary across the simulated SBML observables."
},
{
"name": "species_labels",
"maps_to": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.species_labels",
"description": "Mapping from selected raw SBML observable symbols to display labels."
}
]
},
"tags": [
"biomodels_ebi",
"curated",
"drug-response",
"faithful",
"oncology",
"pharmacology",
"physiology",
"sbml",
"systemsbiology",
"tumor-growth"
],
"title": "Giani2019 - Computational modeling to predict MAP3K8 effects as mediator of resistance to vemurafenib in thyroid cancer stem cells Lab",
"models": [
{
"path": "owned/models/oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model",
"alias": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model",
"provenance": {
"owned_path": "owned/models/oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model"
}
},
{
"path": "owned/models/visualisation",
"alias": "visualisation",
"provenance": {
"owned_path": "owned/models/visualisation"
}
}
],
"wiring": [
{
"to": [
"visualisation.oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model_state"
],
"from": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.state"
},
{
"to": [
"visualisation.oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model_summary"
],
"from": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.summary"
},
{
"to": [
"visualisation.oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model_species_labels"
],
"from": "oncology_sbml_giani2019_computational_modeling_to_predict_map3_biomd0000000883_model.species_labels"
}
],
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"description": "Computational modeling to predict MAP3K8 effects as mediator of resistance to vemurafenib in thyroid cancer stem cells. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.",
"schema_version": "2.0"
}Sign in to start your own run. Public-lab history stays visible here.
Select a run from History to view its results.